Interferon-free antiviral therapy does not increase the risk of developing short term hepatocellular carcinoma in patients with cirrhosis infected with hepatitis C virus

被引：1
|
作者：
Nunez, A. [1 ]
Aguilera, V. [1 ]
Sanchez-Torrijos, Y. [1 ]
Sousa, J. M. [1 ,2 ]
Ferrer, M. T. [1 ,2 ]
Giraldez, A. [1 ,2 ]
Ampuero, J. [3 ,4 ]
Perez-Martinez, J. [1 ]
Cuaresma, M. [2 ,5 ]
Ruiz-Perez, R. [2 ,5 ]
Pascasio, J. M. [3 ,4 ]
机构：
[1] Hosp Univ Virgen del Rocio, Digest Dis, Seville, Spain
[2] Hosp Univ Virgen del Rocio, IBIS, Seville, Spain
[3] Hosp Univ Virgen del Rocio, IBIS, Digest Dis, Seville, Spain
[4] Hosp Univ Virgen del Rocio, CIBERehd, Seville, Spain
[5] Hosp Univ Virgen del Rocio, FISEVI, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31325-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-131
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [21] Interferon-free antiviral therapy for chronic hepatitis C among patients in the liver transplant setting
    van Tilborg, Marjolein
    Maan, Raoel
    van der Meer, Adriaan J.
    de Knegt, Robert J.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2017, 31 (02) : 219 - 225
  • [22] Interferon-free, direct-acting antiviral therapy for chronic hepatitis C
    Gutierrez, J. A.
    Lawitz, E. J.
    Poordad, F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (11) : 861 - 870
  • [23] Interferon-Free Antiviral Therapy Rapidly Improves Thrombocytopenia in Patients with Advanced Chronic Hepatitis C
    Ishizu, Yoji
    Ishigami, Masatoshi
    Ito, Takanori
    Kuzuya, Teiji
    Honda, Takashi
    Hirooka, Yoshiki
    HEPATOLOGY, 2018, 68 : 1157A - 1158A
  • [24] Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence
    Donato, Maria Francesca
    Invernizzi, Federica
    Rossi, Giorgio
    Iavarone, Massimo
    JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1355 - 1356
  • [25] Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence"
    Yang, Ju Dong
    Leise, Michael D.
    JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1357 - 1357
  • [26] Electrocardiographic alterations during interferon-free direct-acting antiviral therapy for hepatitis C virus
    Garcia-Arribas, D.
    Lopez-Garcia, O. N.
    Olmos, C.
    Higueras Nafria, J.
    Devesa Medina, M. J.
    Cuenca Alarcon, F.
    Izquierdo Rubio, S.
    Maroto Castellanos, M.
    Rey Diaz-Rubio, E.
    EUROPEAN HEART JOURNAL, 2017, 38 : 578 - 578
  • [27] INTERFERON AND RISK OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C RELATED CIRRHOSIS
    Kimer, Nina
    Gluud, Lise L.
    Dahl, Emilie K.
    Krag, Aleksander
    HEPATOLOGY, 2011, 54 : 1272A - 1272A
  • [28] Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
    Fukushima, W
    Tanaka, T
    Ohfuji, S
    Habu, D
    Tamori, A
    Kawada, N
    Sakaguchi, H
    Takeda, T
    Nishiguchi, S
    Seki, S
    Shiomi, S
    Hirota, Y
    HEPATOLOGY RESEARCH, 2006, 34 (03) : 141 - 149
  • [29] Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosis
    Kutsenko, A.
    Le, A.
    Trinh, S.
    Dang, H.
    Nguyen, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S125 - S126
  • [30] METABOLIC RISK FACTORS INCREASE THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS C CIRRHOSIS
    Kutsenko, Alina
    Le, An K.
    Dang, Hansen
    Trinh, Sam
    Nguyen, Pauline
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1077 - S1077
12345